PETS — PetMed Express, Inc.

Summary of PetMed Express Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Net Sales: $53 million, a 19% decline from $65.3 million year-over-year, primarily due to a 34% reduction in gross advertising.
• Gross Profit: $14.9 million, down from $17.9 million last year, with a gross profit margin of 28.1%, an 80 basis point improvement year-over-year.
• General and Administrative Expenses: $10.8 million, a 19.7% decrease from $13.4 million last year.
• Advertising Expenses: $3 million, down from $5.8 million, reflecting a strategic pullback to prioritize profitability.
• Net Loss: $700,000 or $0.03 per diluted share, an improvement from a net loss of $2 million or $0.10 per diluted share last year.
• Adjusted EBITDA: $2 million, up from $900,000 in the prior year period.
• Cash Position: $50 million in cash and cash equivalents, with no debt.

2. Strategic Updates and Business Highlights

• The company is focused on repositioning itself as a leader in consumer pet healthcare, with significant progress in integrating PetCareRx operations and targeting $5 million in annualized savings.
• Enhancements to the digital shopping experience include a full website refresh, relaunch of mobile apps, and the introduction of a "Buy Now, Pay Later" payment option.
• Customer acquisition efforts led to 63,000 new customers with shipped orders during the quarter.
• SKU optimization resulted in the elimination of 4,000 underperforming SKUs, improving inventory efficiency with a 66% reduction in total inventory on hand.

3. Forward Guidance and Outlook

• The company anticipates increased investments in customer engagement, acquisition, and infrastructure enhancements in the short term.
• Plans to refine marketing strategies and improve customer experience to drive sustainable growth and shareholder value.
• Management acknowledges the need for a strategic reset in marketing to ensure profitability while capturing a younger consumer demographic.

4. Bad News, Challenges, or Points of Concern

• The company has experienced three consecutive quarters of double-digit revenue declines, attributed to a highly competitive market and a strategic pullback in marketing spend.
• Customer spending is under pressure, with reduced visits to veterinarians and lower prescription volumes.
• The need to capture younger consumers (Millennials and Gen Z) is critical, as current marketing efforts have not effectively reached this demographic.
• Conversion rates remain a challenge, despite improvements in website performance metrics.

5. Notable Q&A Insights

• Management clarified that the recent SKU rationalization did not significantly impact revenue, as many eliminated SKUs were not consistently sold.
• The competitive landscape is dynamic, with consumers showing a preference for lower-priced options, although higher-income households continue to spend on pet healthcare.
• Future marketing investments will be made cautiously, focusing on foundational improvements before ramping up promotional efforts.
• The company is committed to enhancing last-mile delivery capabilities to meet consumer expectations for timely product delivery.

Overall, while PetMed Express is making strides in its strategic transformation and cost management, it faces significant challenges in revenue growth and customer acquisition in a competitive market.